Specific and dual antagonists of α4β1 and α4β7 integrins
- 21 January 2002
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (2) , 133-136
- https://doi.org/10.1016/s0960-894x(01)00705-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The design and synthesis of potent cyclic peptide VCAM–VLA-4 antagonists incorporating an achiral Asp-Pro mimeticBioorganic & Medicinal Chemistry Letters, 2000
- Cyclic thioether peptide mimetics as VCAM–VLA-4 antagonistsBioorganic & Medicinal Chemistry Letters, 2000
- Carbacyclic peptide mimetics as VCAM–VLA-4 antagonistsBioorganic & Medicinal Chemistry Letters, 2000
- Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonistsBioorganic & Medicinal Chemistry Letters, 2000
- Discovery and evaluation of potent, cysteine-based α4β1 integrin antagonistsBioorganic & Medicinal Chemistry Letters, 2000
- N -Acyl phenylalanine analogues as potent small molecule VLA-4 antagonistsBioorganic & Medicinal Chemistry Letters, 2000
- N -Benzylpyroglutamyl- l -phenylalanine derivatives as VCAM/VLA-4 antagonistsBioorganic & Medicinal Chemistry Letters, 2000
- Novel inhibitors of α4β1 integrin receptor interactions through library synthesis and screeningBioorganic & Medicinal Chemistry Letters, 1998
- Leukocyte-endothelial cell interactions: Molecular mechanisms and implications in gastrointestinal diseaseGastroenterology, 1998
- Very late antigen 4 (VLA4) antagonists as anti-inflammatory agentsCurrent Opinion in Chemical Biology, 1998